Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast

被引:15
作者
Hasebe, T
Sasaki, S
Imoto, S
Ochiai, A
机构
[1] Natl Canc Ctr, Res Inst E, Div Pathol, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr, Res Inst E, Epidemiol & Biostat Div, Kashiwa, Chiba 2778577, Japan
[3] Natl Canc Ctr Hosp E, Dept Breast Surg, Kashiwa, Chiba 2778577, Japan
关键词
D O I
10.1111/j.1349-7006.2003.tb01416.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is no study evaluating the significance of nodal metastatic tumor characteristics in tumor progression of invasive ductal carcinomas (IDCs) of the breast. The purpose of this study was to investigate whether nodal metastatic tumor characteristics play an important role in the tumor progression of IDCs. The subjects of this study were 205 IDC patients with nodal metastases. Significant associations with increased numbers of nodal metastases, and patient outcomes were evaluated by multivariate analyses, in comparison with well-known histological parameters. The numbers of lymph nodes with extra-nodal invasion and with extranodal blood vessel tumor emboli, the distance of extra-nodal blood vessel tumor emboli from the nodes, and the nodal tumor dimensions significantly increased the number of nodal metastases in the multivariate analysis (P<0.001). Cox multivariate analyses showed that the parameters which significantly increased hazard rates (HRs) of disease-free survival (DFS), distant organ metastasis (DOM) and overall survival were 6 or more mitotic figures of nodal metastatic tumors (P<0.05). Six or more lymph nodes with extra-nodal invasion, and an extra-nodal blood vessel tumor emboli dimension of >0.6 mm significantly increased the HRs of DFS and DOM in multivariate analyses (P<0.05). The present study demonstrated the important roles of nodal metastatic tumors in the tumor progression of IDCs. (Cancer Sci 2003; 94: 181-187).
引用
收藏
页码:181 / 187
页数:7
相关论文
共 29 条
[1]   Cell proliferation measured by MIB1 and timing of surgery for breast cancer [J].
Cooper, LS ;
Gillett, CE ;
Smith, P ;
Fentiman, IS ;
Barnes, DM .
BRITISH JOURNAL OF CANCER, 1998, 77 (09) :1502-1507
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]  
Crowe David L., 2000, Molecular Cell Biology Research Communications, V3, P243, DOI 10.1006/mcbr.2000.0221
[4]  
DONEGAN WL, 1993, CANCER, V72, P778, DOI 10.1002/1097-0142(19930801)72:3<778::AID-CNCR2820720324>3.0.CO
[5]  
2-J
[6]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[7]  
FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO
[8]  
2-3
[9]  
FISHER B, 1970, SURG GYNECOL OBSTETR, V131, P79
[10]   Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy? [J].
Fisher, BJ ;
Perera, FE ;
Cooke, AL ;
Opeitum, A ;
Dar, AR ;
Venkatesan, VM ;
Stitt, L ;
Radwan, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03) :551-559